Structure via PubChem · Public domain (PubChem)
brinzolamide
Sign in to saveBrinzolamide (trade name Azopt) is a carbonic anhydrase inhibitor used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Chemical data
- Formula
- C12H21N3O5S3
- Molecular weight
- 383.5 g/mol
- IUPAC name
- (4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-3,4-dihydrothieno[3,2-e]thiazine-6-sulfonamide
- SMILES
- CCN[C@H]1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
- InChIKey
- HCRKCZRJWPKOAR-JTQLQIEISA-N
- XLogP
- -0.3
- Polar surface area
- 164 Ų
- H-bond donors
- 2
- H-bond acceptors
- 9
- Formal charge
- 0
via PubChem
Research
508 papers- Brinzolamide.2006
- Brinzolamide.Expert opinion on pharmacotherapy · 2008
- Preclinical overview of brinzolamide.Survey of ophthalmology · 2000
- Brinzolamide/brimonidine: a review of its use in patients with open-angle glaucoma or ocular hypertension.Drugs & aging · 2015
- Brinzolamide-induced Follicular Conjunctivitis.Journal of glaucoma · 2018
via PubMed
Wikidata facts
- Mass
- 383.064
Show 6 more facts
- defined daily dose
- 0.2
- chemical formula
- C₁₂H₂₁N₃O₅S₃
- World Health Organisation international non-proprietary name
- brinzolamide
- isomeric SMILES
- CCN[C@H]1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
- Commons category
- Brinzolamide
- canonical SMILES
- CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
via Wikidata · CC0
~4 min read
Article
16 sectionsContents
- Chemistry
- Indications
- Pharmacodynamics
- Pharmacokinetics
- Absorption
- Distribution
- Metabolism
- Excretion
- Cautions
- Side effects
- Precautions
- Combinations
- With timolol
- With brimonidine
- References
- Further reading
Brinzolamide (trade name Azopt) is a carbonic anhydrase inhibitor used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Brinzolamide was approved as a generic medication in the United States in November 2020.
Connections
glaucoma
Entity
kidney
Entity
red blood cell
Entity
digital object identifier
Entity
chemical formula
Entity
molar mass
Entity
Q180686
Entity
excretion
Entity
acetylcholine
Entity
CAS Registry Number
Entity
Q229883
Entity
PubChem
Entity
United States Food and Drug Administration
Entity
Anatomical Therapeutic Chemical Classification System
Entity
generic drug
Medication
pharmacokinetics
Entity
MedlinePlus
Entity
beta blocker
Entity
simplified molecular input line entry specification
Entity
chronic renal insufficiency
Entity